Clearside Biomedical Return On Equity vs. Shares Owned By Institutions

CLSD Stock  USD 1.02  0.02  2.00%   
Taking into consideration Clearside Biomedical's profitability measurements, Clearside Biomedical's profitability may be sliding down. It has an above-average probability of reporting lower numbers next quarter. Profitability indicators assess Clearside Biomedical's ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
2.04154098
Current Value
2.14
Quarterly Volatility
6.75256366
 
Credit Downgrade
 
Yuan Drop
 
Covid
As of December 14, 2024, Price To Sales Ratio is expected to decline to 8.35. In addition to that, Days Sales Outstanding is expected to decline to 8.24. At present, Clearside Biomedical's Income Quality is projected to drop slightly based on the last few years of reporting.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin1.020.9568
Notably Up
Slightly volatile
For Clearside Biomedical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Clearside Biomedical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Clearside Biomedical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Clearside Biomedical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Clearside Biomedical over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.45)
Revenue Per Share
0.112
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.44)
Return On Equity
(13.10)
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Clearside Biomedical Shares Owned By Institutions vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Clearside Biomedical's current stock value. Our valuation model uses many indicators to compare Clearside Biomedical value to that of its competitors to determine the firm's financial worth.
Clearside Biomedical is rated below average in return on equity category among its peers. It is rated below average in shares owned by institutions category among its peers . At present, Clearside Biomedical's Return On Equity is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Clearside Biomedical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Clearside Shares Owned By Institutions vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Clearside Biomedical

Return On Equity

 = 

Net Income

Total Equity

 = 
-13.1
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Clearside Biomedical

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
23.16 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Clearside Shares Owned By Institutions Comparison

Clearside Biomedical is currently under evaluation in shares owned by institutions category among its peers.

Clearside Biomedical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Clearside Biomedical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Clearside Biomedical will eventually generate negative long term returns. The profitability progress is the general direction of Clearside Biomedical's change in net profit over the period of time. It can combine multiple indicators of Clearside Biomedical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-24.8 M-26.1 M
Income Before Tax-32.5 M-34.1 M
Total Other Income Expense Net-7.6 M-7.3 M
Net Loss-32.5 M-34.1 M
Income Tax Expense-100.9 K-95.9 K
Net Loss-32.5 M-34.1 M
Net Loss-37.9 M-39.8 M
Interest Income289.8 K257.6 K
Non Operating Income Net Other769.4 K807.8 K
Net Interest Income-9.4 M-8.9 M
Change To Netincome5.7 M3.6 M
Net Loss(0.53)(0.55)
Income Quality 0.56  0.59 
Net Income Per E B T 0.93  0.81 

Clearside Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Clearside Biomedical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Clearside Biomedical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Clearside Biomedical's important profitability drivers and their relationship over time.

Use Clearside Biomedical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clearside Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearside Biomedical will appreciate offsetting losses from the drop in the long position's value.

Clearside Biomedical Pair Trading

Clearside Biomedical Pair Trading Analysis

The ability to find closely correlated positions to Clearside Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clearside Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clearside Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clearside Biomedical to buy it.
The correlation of Clearside Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clearside Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clearside Biomedical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clearside Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Clearside Biomedical position

In addition to having Clearside Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Adviser Favorites Thematic Idea Now

Adviser Favorites
Adviser Favorites Theme
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:
Check out Trending Equities.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
To fully project Clearside Biomedical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Clearside Biomedical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Clearside Biomedical's income statement, its balance sheet, and the statement of cash flows.
Potential Clearside Biomedical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Clearside Biomedical investors may work on each financial statement separately, they are all related. The changes in Clearside Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearside Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.